[In vitro suppressive effect of angelica polysaccharide on human cytomegalovirus-induced apoptosis via direct infection in CHRF-288-11 cells].
The objective of study was to investigate the in vitro suppressive effect of angelica polysaccharide (APS) on human cytomegalovirus-induced apoptosis via direct infection in CHRF-288-11 cells. HCMV AD169 directly infected CHRF-288-11 were cultured in vitro, APS in different doses were added on day 3 after the infection of virus. Cells of every group were collected at different time points. HCMV DNA of cells were detected by using polymerase chain reaction and the apoptotic cells were examined by using Hoechst staining, MTT assay, DNA fragmentation assay and flow cytometry. The results showed that the APS to some extent inhibited the apoptosis of CHRF cells infected by HCMV in vitro in a dose-dependent manner. The expression of HCMV IEA in CHRF-288-11 cells was found by PCR amplification. Morphology observation, flow cytometry assay and DNA fragmentation assay revealed the existence of apoptosis. With the dose decrease of APS added to the infected CHRF cells, the percentage of apoptotic cells increased. It is concluded that the HCMV AD169 can infect CHRF cells directly in vitro and decrease cell viability. HCMV AD169 infection increases the apoptosis of CHRF cells in time-dependent manner. When APS was added to the CHRF cells infected by HCMV AD169 in vitro, the viability of CHRF cells increase, which indicated that APS to some extent protects the CHRF cells infected by HCMV. APS suppresses the cytomegalovirus-induced apoptosis in CHRF cells directly infected in vitro in dose-dependent manner.
Zhang
Ping-Ping
PP
Department of Pediatrics, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China.
Wang
Qing-Wen
QW
Chen
Hui-Qin
HQ
Li
Xiao-Feng
XF
Dou
Juan
J
Chen
Jian-Liang
JL
He
Zheng-Xian
ZX
Yang
Mo
M
D029969:Angelica / Q000737:chemistry; D017209:Apoptosis / Q000187:drug effects*; D002478:Cells, Cultured; D003587:Cytomegalovirus; D006801:Humans; D008533:Megakaryocytes / Q000166:cytology* / Q000187:drug effects* / Q000821:virology; D011134:Polysaccharides / Q000494:pharmacology*
D011134:Polysaccharides